INFECTIMUNE

Welcome to the Brand page for “INFECTIMUNE”, which is offered here for Pharmaceutical research services, the use of cationic lipid nanotechnology to stimulate immune responses for the purpose of identifying and developing pharmaceutical candidates;.

Its status is currently believed to be active. Its class is unavailable. “INFECTIMUNE” is believed to be currently owned by “PDS Biotechnology Corporation”.

Owner:
PDS BIOTECHNOLOGY CORPORATION
Owner Details
Description:
Pharmaceutical research services, the use of cationic lipid nanotechnology to stimulate immune responses for the purpose of identifying and developing pharmaceutical candidates;
Categories: PHARMACEUTICAL RESEARCH SERVICES